世界の感染症体外診断市場2021-2028:製品別、用途別、技術別(イムノアッセイ、分子診断)、最終用途別、地域別

◆英語タイトル:Infectious Disease In-vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunoassay, Molecular Diagnostics), By End-use, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21AR022
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年4月15日
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の感染症体外診断市場規模が2028年までに760億ドルに達すると予測しています。2021年から2028年までに年平均3.9%成長する見通しです。本市場調査レポートでは、感染症体外診断の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別(器具、試薬、サービス)分析、技術別(イムノアッセイ、分子診断、微生物学、その他)分析、用途別(MRSA、連鎖球菌、クロストリジウム・ディフィシル、バンコマイシン耐性腸球菌(VRE)、カルバペネム耐性腸内細菌検査(CRE)、呼吸器ウイルス)分析、最終用途別(ポイントオブケア、中央検査室、その他)分析、地域別分析、競争状況などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界の感染症体外診断市場規模:製品別(器具、試薬、サービス)
・世界の感染症体外診断市場規模:技術別(イムノアッセイ、分子診断、微生物学、その他)
・世界の感染症体外診断市場規模:用途別(MRSA、連鎖球菌、クロストリジウム・ディフィシル、バンコマイシン耐性腸球菌(VRE)、カルバペネム耐性腸内細菌検査(CRE)、呼吸器ウイルス)
・世界の感染症体外診断市場規模:最終用途別(ポイントオブケア、中央検査室、その他)
・世界の感染症体外診断市場規模:地域別
・競争状況
【レポートの概要】

Infectious Disease In-vitro Diagnostics Market Growth & Trends

The global infectious disease in-vitro diagnostics market size is expected to reach USD 76.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.9% from 2021 to 2028. This growth is owing to factors such as the increasing prevalence of infectious diseases, the outbreak of COVID-19, growing market penetration of available treatments, and increasing consumer awareness.

Diagnostics for SARS-CoV-2 detection are being continuously launched for catering to markets that have specific regulatory requirements. For instance, in September 2019, Roche launched its CE Marked antibody diagnostic test Elecsys Anti-SARS-CoV-2 S. Thus, the launch of new diagnostics is expected to lead to an increase in demand owing to their usage in the characterization of the vaccine-induced immune response, thereby boosting vaccine development.

Technological advancements, such as the introduction of portable instruments like Cobas 4800 developed by Roche Diagnostics and GeneXpert by Cepheid are expected to drive market growth over the forecast period. Furthermore, increasing use of these systems to develop new tests that can detect infectious diseases is expected to fuel market growth.

An increase in the prevalence of MRSA infection, high consumer awareness, and the presence of high unmet patient needs are some of the factors expected to drive the market during the forecast period. Diagnosis of MRSA infection involves rapid culture methods and molecular techniques for assessment of MRSA colonization. The presence of a large number of diagnostic tests and the introduction of new products, such as LightCycler, TaqMan, RotorGene, and Stratagene, are expected to propel segment growth.

The launch of new products is becoming a key strategy adopted by players, as new SARS-CoV-2 diagnostics are being launched by major players such as BD, bioMérieux SA, and F. Hoffmann-La Roche Ltd. For instance, in March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, and BioMedomics launched a PoC COVID-19 test that can detect antibodies in blood within 15 minutes.

Infectious Disease In-vitro Diagnostics Market Report Highlights

• The reagents segment dominated the overall market majorly driven by the high usage rate

• The molecular diagnostics technology segment accounted for the highest revenue share in 2020. This can be attributed to the usage of PCR test for Covid-19 diagnosis

• The central laboratories segment accounted for a revenue share of around 60.0% in 2020

• North America accounted for the largest revenue share in 2020, driven by a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure

• The market is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Technology
1.1.3 Application
1.1.4 Test Location
1.1.5 Regional Scope
1.1.6 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Insights
2.3 Competitive Insights
Chapter 3 Infectious Diseases In Vitro Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.3.3 List of key end users
3.4 Regulatory Framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Growing geriatric population
3.5.1.2 Technological advancements
3.5.1.3 High demand for PoC facilities
3.5.1.4 Increasing prevalence of infectious diseases
3.5.1.5 External funding for R&D activities
3.5.2 Market restraint analysis
3.5.2.1 High prices of IVD tests
3.5.3 Industry challenges
3.5.3.1 Presence of ambiguous regulatory framework
3.6 Infectious Diseases In Vitro Diagnostics Market Analysis Tools
3.6.1 Industry analysis – Porter’s
3.6.2 PESTLE Analysis
3.6.3 Major deals and strategic alliances analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Marketing & promotions
3.6.4 Market entry strategies
Chapter 4 Infectious Diseases In Vitro Diagnostics Market – Segment Analysis, By Product, 2017 – 2028 (USD Million)
4.1 Definition and Scope
4.2 Product Type Market Share Analysis, 2020 & 2028
4.3 Segment Dashboard
4.4 Global Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 to 2028
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2017 – 2028 (USD Million)
4.5.2 Reagents
4.5.2.1 Reagents market estimates and forecast, 2017 – 2028 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 5 Infectious Diseases In Vitro Diagnostics Market – Segment Analysis, By Technology, 2017 – 2028 (USD Million)
5.1 Definition and Scope
5.2 Technology Type Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Infectious Diseases In Vitro Diagnostics Market, by Technology, 2017 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
5.5.1 Immunoassay
5.5.1.1 Immunoassay market estimates and forecast, 2017 – 2028 (USD Million)
5.5.2 Molecular diagnostics
5.5.2.1 Molecular diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
5.5.3 Microbiology
5.5.3.1 Microbiology market estimates and forecast, 2017 – 2028 (USD Million)
5.5.4 Others
5.5.4.1 Others market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 6 Infectious Diseases In Vitro Diagnostics Market – Segment Analysis, By Application, 2017 – 2028 (USD Million)
6.1 Definition and Scope
6.2 Application Type Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global Infectious Diseases In Vitro Diagnostics Market, by Application, 2017 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
6.5.1 MRSA
6.5.1.1 MRSA market estimates and forecast, 2017 – 2028 (USD Million)
6.5.2 Streptococcus
6.5.2.1 Streptococcus market estimates and forecast, 2017 – 2028 (USD Million)
6.5.3 Clostridium difficile
6.5.3.1 Clostridium difficile market estimates and forecast, 2017 – 2028 (USD Million)
6.5.4 Vancomycin-resistant enterococci (VRE)
6.5.4.1 VRE market estimates and forecast, 2017 – 2028 (USD Million)
6.5.5 Carbapenem-resistant enterobacterial testing (CRE)
6.5.5.1 CRE market estimates and forecast, 2017 – 2028 (USD Million)
6.5.6 Respiratory virus
6.5.6.1 Respiratory virus market estimates and forecast, 2017 – 2028 (USD Million)
6.5.7 Candida
6.5.7.1 Candida market estimates and forecast, 2017 – 2028 (USD Million)
6.5.8 Tuberculosis (TB) & drug-resistant TB
6.5.8.1 TB & drug-resistant TB market estimates and forecast, 2017 – 2028 (USD Million)
6.5.9 Gastrointestinal (GI) panel testing
6.5.9.1 GI panel testing market estimates and forecast, 2017 – 2028 (USD Million)
6.5.10 Chlamydia
6.5.10.1 Chlamydia market estimates and forecast, 2017 – 2028 (USD Million)
6.5.11 Gonorrhea
6.5.11.1 Gonorrhea market estimates and forecast, 2017 – 2028 (USD Million)
6.5.12 Human Papillomavirus (HPV)
6.5.12.1 HPV market estimates and forecast, 2017 – 2028 (USD Million)
6.5.13 Human Immunodeficiency Virus (HIV)
6.5.13.1 HIV market estimates and forecast, 2017 – 2028 (USD Million)
6.5.14 Hepatitis C
6.5.14.1 Hepatitis C market estimates and forecast, 2017 – 2028 (USD Million)
6.5.15 Hepatitis B
6.5.15.1 Hepatitis B market estimates and forecast, 2017 – 2028 (USD Million)
6.5.16 COVID-19
6.5.16.1 COVID-19 market estimates and forecast, 2017 – 2028 (USD Million)
6.5.17 Others
6.5.17.1 Others market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 7 Infectious Diseases In Vitro Diagnostics Market – Segment Analysis, By End Use, 2017 – 2028 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2020 & 2028
7.3 Segment Dashboard
7.4 Global Infectious Diseases In Vitro Diagnostics Market, by end use, 2017 to 2028
7.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
7.5.1 Point of care
7.5.1.1 Point of care market estimates and forecast, 2017 – 2028 (USD Million)
7.5.2 Central laboratories
7.5.2.1 Central laboratories market estimates and forecast, 2017 – 2028 (USD Million)
7.5.3 Others
7.5.3.1 Others market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 8 Infectious Diseases In Vitro Diagnostics Market – Segment Analysis, By Region, 2017 – 2028 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2020 & 2028
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 Regional Market Share and Leading Players, 2020
8.5.1 North america
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East and Africa
8.6 SWOT Analysis
8.6.1 North America
8.6.2 Europe
8.6.3 Asia Pacific
8.6.4 Latin America
8.6.5 Middle East and Africa
8.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2020 to 2028
8.7.1 North America
8.7.1.1 North America market estimates and forecast, 2017-2028 (USD Million)
8.7.1.2 U.S.
8.7.1.2.1 U.S. infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.1.3 Canada
8.7.1.3.1 Canada Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.2 Europe
8.7.2.1 Europe market estimates and forecast, 2017-2028 (USD Million)
8.7.2.2 U.K.
8.7.2.2.1 U.K. Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.2.3 Germany
8.7.2.3.1 Germany Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.2.4 Spain
8.7.2.4.1 Spain Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.2.5 France
8.7.2.5.1 France Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.2.6 Italy
8.7.2.6.1 Italy Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.3 Asia Pacific
8.7.3.1 Asia Pacific market estimates and forecast estimates and forecast, 2017-2028 (USD Million)
8.7.3.2 Japan
8.7.3.2.1 Japan Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.3.3 China
8.7.3.3.1 China Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.3.4 India
8.7.3.4.1 India Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.3.5 South Korea
8.7.3.5.1 South Korea Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.3.6 Australia
8.7.3.6.1 Australia Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.4 Latin America
8.7.4.1 Latin America market estimates and forecast estimates and forecast, 2017-2028 (USD Million)
8.7.4.2 Brazil
8.7.4.2.1 Brazil Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.4.3 Mexico
8.7.4.3.1 Mexico Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.4.4 Argentina
8.7.4.4.1 Argentina Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.5 MEA
8.7.5.1 MEA market estimates and forecast estimates and forecast, 2017-2028 (USD Million)
8.7.5.2 South Africa
8.7.5.2.1 South Africa Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.5.3 Saudi Arabia
8.7.5.3.1 Saudi Arabia Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
8.7.5.4 UAE
8.7.5.4.1 UAE Infectious diseases in vitro diagnostics market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 9 COMPETITIVE LANDSCAPE
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.3.3 Key company market share analysis, 2020
9.4 Public Companies
9.4.1 Company market position analysis
9.4.2 Company Market Share, by region, 2020
9.4.3 Competitive Dashboard Analysis
9.4.3.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 Becton, Dickinson and Company
9.6.1.1 Company Overview
9.6.1.2 Financial Performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic initiatives
9.6.2 bioMérieux SA
9.6.2.1 Company overview
9.6.2.2 Financial Performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 Abbott
9.6.3.1 Company Overview
9.6.3.2 Financial Performance
9.6.3.3 Product Benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Quidel Corporation
9.6.4.1 Company Overview
9.6.4.2 Financial Performance
9.6.4.3 Product Benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 OraSure Technologies, Inc
9.6.5.1 Company Overview
9.6.5.2 Financial Performance
9.6.5.3 Product Benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Hologic Inc. (Gen Probe)
9.6.6.1 Company Overview
9.6.6.2 Financial Performance
9.6.6.3 Product Benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 Cepheid (Danaher)
9.6.7.1 Company Overview
9.6.7.2 Financial Performance
9.6.7.3 Product Benchmarking
9.6.7.4 Strategic Initiatives
9.6.8 Qiagen
9.6.8.1 Company Overview
9.6.8.2 Financial Performance
9.6.8.3 Product Benchmarking
9.6.8.4 Strategic Initiatives
9.6.9 F. Hoffmann-La Roche Ltd.
9.6.9.1 Company Overview
9.6.9.2 Financial Performance
9.6.9.3 Product Benchmarking
9.6.9.4 Strategic Initiatives
9.6.10 Siemens Healthcare GmbH
9.6.10.1 Company Overview
9.6.10.2 Financial Performance
9.6.10.3 Product Benchmarking
9.6.10.4 Strategic Initiatives
9.6.11 Bio-Rad Laboratories, Inc.
9.6.11.1 Company Overview
9.6.11.2 Financial Performance
9.6.11.3 Product Benchmarking
9.6.11.4 Strategic Initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Infectious Diseases In Vitro Diagnostics Market, By Region, 2017 - 2028 (USD Million)
TABLE 5 Global Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 6 Global Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 7 Global Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 8 Global Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 9 North America Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 10 North America Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 11 North America Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 12 North America Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 13 North America Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 14 U.S. Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 15 U.S. Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 16 U.S. Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 17 U.S. Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 18 Canada Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 19 Canada Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 20 Canada Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 21 Canada Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 22 Europe Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 23 Europe Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 24 Europe Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 25 Europe Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 26 Europe Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 27 U.K. Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 28 U.K. Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 29 U.K. Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 30 U.K. Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 31 Germany Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 32 Germany America Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 33 Germany America Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 34 Germany America Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 35 France Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 36 France Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 37 France Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 38 France Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 39 Spain Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 40 Spain Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 41 Spain Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 42 Spain Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 43 Italy Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 44 Italy Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 45 Italy Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 46 Italy Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 47 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 48 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 49 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 50 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 51 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 52 China Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 53 China Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 54 China Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 55 China Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 56 Japan Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 57 Japan Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 58 Japan Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 59 Japan Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 60 India Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 61 India Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 62 India Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 63 India Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 64 South Korea Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 65 South Korea Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 66 South Korea Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 67 South Korea Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 68 Australia Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 69 Australia Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 70 Australia Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 71 Australia Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 72 Latin America Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 73 Latin America Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 74 Latin America Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 75 Latin America Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 76 Latin America Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 77 Brazil Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 78 Brazil Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 79 Brazil Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 80 Brazil Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 81 Mexico Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 82 Mexico Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 83 Mexico Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 84 Mexico Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 85 Argentina Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 86 Argentina Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 87 Argentina Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 88 Argentina Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 89 MEA Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 90 MEA Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 91 MEA Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 92 MEA Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 93 MEA Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 94 South Africa Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 95 South Africa Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 96 South Africa Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 97 South Africa Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 98 UAE Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 99 UAE Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 100 UAE Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 101 UAE Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 102 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 103 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 104 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 105 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)

List of Figures

Fig. 1 Infectious Diseases In Vitro Diagnostics Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Primary interviews in North America
Fig. 6 Primary interviews in Europe
Fig. 7 Primary interviews in Asia Pacific
Fig. 8 Primary interviews in Middle East and Africa
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Infectious diseases in vitro diagnostics market snapshot
Fig. 14 Segment Insights
Fig. 15 Strategy framework
Fig. 16 Penetration & growth prospect mapping
Fig. 17 Consumer behavior analysis
Fig. 18 Factors influencing North America Infectious Diseases In Vitro Diagnostics Market (%)
Fig. 19 Factors influencing Europe Infectious Diseases In Vitro Diagnostics Market (%)
Fig. 20 Factors influencing Asia Pacific Infectious Diseases In Vitro Diagnostics Market (%)
Fig. 21 Factors influencing Latin America Infectious Diseases In Vitro Diagnostics Market (%)
Fig. 22 Factors influencing Middle East and Africa Infectious Diseases In Vitro Diagnostics Market (%)
Fig. 23 Market driver relevance analysis (Current & future impact)
Fig. 24 Global population growth, by age-group, 2012 - 2020 (Million)
Fig. 25 Global percentage of population, by age group, 2000 and 2050
Fig. 26 General trend of CLIA-waived tests
Fig. 27 Market restraint relevance analysis (Current & future impact)
Fig. 28 Porter’s five forces analysis
Fig. 29 PESTLE analysis
Fig. 30 Strategy mapping
Fig. 31 Infectious Diseases In Vitro Diagnostics Market: Product movement analysis
Fig. 32 Product segment dashboard
Fig. 33 Infectious Diseases In Vitro Diagnostics Market product outlook: Key takeaways
Fig. 34 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 35 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 36 Services market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 37 Infectious Diseases In Vitro Diagnostics Market: Technology movement analysis
Fig. 38 Technology segment dashboard
Fig. 39 Infectious Diseases In Vitro Diagnostics Market technology outlook: Key takeaways
Fig. 40 Immunoassay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 41 Molecular diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 42 Microbiology market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 43 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 44 Infectious Diseases In Vitro Diagnostics Market: Application movement analysis
Fig. 45 Application segment dashboard
Fig. 46 Infectious Diseases In Vitro Diagnostics Market application outlook: Key takeaways
Fig. 47 MRSA market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 48 Streptococcus market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 49 Clostridium difficile market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 50 VRE market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 51 CRE market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 52 Respiratory virus market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 53 Candida market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 54 TB & drug-resistant TB market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 55 GI panel testing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 56 Chlamydia market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 57 Gonorrhea market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 58 HPV market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 59 HIV market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 60 Hepatitis C market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 61 Hepatitis B market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 62 COVID-19 market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 63 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 64 Infectious Diseases In Vitro Diagnostics Market: End-use movement analysis
Fig. 65 End-use segment dashboard
Fig. 66 Infectious Diseases In Vitro Diagnostics Market End-use outlook: Key takeaways
Fig. 67 Point of care market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 68 Central laboratories market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 69 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 70 Regional outlook, 2020 & 2028
Fig. 71 Regional market dashboard
Fig. 72 Regional marketplace: Key takeaways
Fig. 73 North America market share and leading players, 2020
Fig. 74 Europe market share and leading players, 2020
Fig. 75 Asia Pacific market share and leading players, 2020
Fig. 76 Latin America market share and leading players, 2020
Fig. 77 Middle East and Africa market share and leading players, 2020
Fig. 78 North America, SWOT
Fig. 79 Europe, SWOT
Fig. 80 Asia Pacific, SWOT
Fig. 81 Latin America, SWOT
Fig. 82 Middle East and Africa, SWOT
Fig. 83 North America
Fig. 84 North America Infectious Diseases In Vitro Diagnostics Market, 2017 - 2028 (USD Million)
Fig. 85 U.S.
Fig. 86 U.S. Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 87 Canada
Fig. 88 Canada Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 89 Europe
Fig. 90 Europe Infectious Diseases In Vitro Diagnostics Market, 2017 - 2028 (USD Million)
Fig. 91 U.K.
Fig. 92 U.K. Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 93 Germany
Fig. 94 Germany Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 95 Spain
Fig. 96 Spain Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 97 France
Fig. 98 France Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 99 Italy
Fig. 100 Italy Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 101 Asia Pacific
Fig. 102 Asia Pacific Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 103 Japan
Fig. 104 Japan Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 105 China
Fig. 106 China Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 107 India
Fig. 108 India Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 109 South Korea
Fig. 110 South Korea Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 111 Australia
Fig. 112 Australia Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 113 Latin America
Fig. 114 Latin America Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 115 Brazil
Fig. 116 Brazil Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 117 Mexico
Fig. 118 Mexico Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 119 Argentina
Fig. 120 Argentina Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 121 MEA
Fig. 122 MEA Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 123 South Africa
Fig. 124 South Africa Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 125 Saudi Arabia
Fig. 126 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 127 UAE
Fig. 128 UAE Infectious Diseases In Vitro Diagnostics Market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 129 Ansoff Matrix
Fig. 130 Heat map analysis
Fig. 131 Company market share analysis
Fig. 132 Company market position analysis
Fig. 133 Company market share, by region, 2020
Fig. 134 Market differentiators

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の感染症体外診断市場2021-2028:製品別、用途別、技術別(イムノアッセイ、分子診断)、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆